As of 2026-04-05, the Relative Valuation of Chinook Therapeutics Inc (KDNY) is (70.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.39 USD, the upside of Chinook Therapeutics Inc based on Relative Valuation is -274.5%.
The range of the Relative Valuation is (64.66) - (73.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 22.7x | 20.4x |
| Forward P/E multiples | 18.0x - 21.5x | 20.8x |
| Fair Price | (64.66) - (73.42) | (70.48) |
| Upside | -260.1% - -281.8% | -274.5% |
| Date | P/E |